%-------------------------------------------------------------------------%
%--------------------Classroom Lecture Model Series-----------------------%
%-------------------------------------------------------------------------%

%-----------------------Work In Progress----------------------------------%
\section{Introduction}

\section{Classroom Lecture 1-3 Topics: Ribosome ER Smooth and Rough}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\section{Classroom Lecture 4-6 Topics:  Translation and Transcription Models}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\section{Classroom Lecture 7-9 Topics:  Normal Mode Analysis Compound Discovery QSAR Models}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\section{Classroom Lecture 10-12 Topics: WDR and G Quadruplexes Heat Shock Proteins}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\section{Classroom Lecture 13-15 Topics: Machine Learning Models I, II and III}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\section{Classroom Lecture 16-18 Topics:  Ribosome Model}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\section{Classroom Lecture 19-21 Topics: Chaperonin Model}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\section{Classroom Lecture 22-24 Topics: Proteasome Model}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\section{Classroom Lecture 25-27 Topics: Network Models Molecular Machines I and II}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\section{Classroom Lecture 28-30 Topics: Application Study I, II and III}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\section{Topic Summary}

\subsection{Topic A:}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\subsection{Topic B:}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\subsection{Topic C:}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\subsection{Topic D:}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\subsection{Topic E:}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Article ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\section{Analysis}

\begin{table}[H]\centering
\begin{tabular}{p{1cm}p{1cm}p{1cm}p{1cm}p{3cm}}
Topic ID & #Articles & Readability & Vocabulary & Search String  \\
\hline
\hline
\end{tabular}
\end{table}

\section{Summary of Topics for Classroom}

\begin{table}[H]\centering
	\begin{tabular}{p{1cm}p{4cm}p{3cm}}
		Topic ID & Summary & Comments\\
		\hline
		\hline
	\end{tabular}
\end{table}

\section{Bibliography}

\subsection{Classroom Lecture 1-3 Topics: Ribosome ER Smooth and Rough}
\subsection{Classroom Lecture 4-6 Topics: Translation and Transcription Models}
\subsection{Classroom Lecture 7-9 Topics: Normal Mode Analysis Compound Discovery QSAR Models}
\subsection{Classroom Lecture 10-12 Topics: WDR and G Quadruplexes Heat Shock Proteins}

\bibitem[1]{key1}Characterization of parallel and antiparallel G-tetraplex structures by vibrational spectroscopy. 
\bibitem[2]{key2}A conformationally constrained nucleotide analogue controls the folding topology of a DNA g-quadruplex. 
\bibitem[3]{key3}Following G-quartet formation by UV-spectroscopy.
\bibitem[1]{key1}Structure of the human telomere in Na+ solution: an antiparallel (2+2) G-quadruplex scaffold reveals additional diversity. 
\bibitem[2]{key2}Interaction of [Ru(bpy)2(dppz)]2+ with human telomeric DNA: preferential binding to G-quadruplexes over i-motif. 
\bibitem[3]{key3}Structure of a two-G-tetrad intramolecular G-quadruplex formed by a variant human telomeric sequence in K+ solution: insights into the interconversion of human telomeric G-quadruplex structures. 
\bibitem[4]{key4}Giardia telomeric sequence d(TAGGG)4 forms two intramolecular G-quadruplexes in K+ solution: effect of loop length and sequence on the folding topology. 
\bibitem[5]{key5}Structure of the human telomere in K+ solution: a stable basket-type G-quadruplex with only two G-tetrad layers. 
\bibitem[6]{key6}Structural polymorphism of intramolecular quadruplex of human telomeric DNA: effect of cations, quadruplex-binding drugs and flanking sequences. 
\bibitem[7]{key7}Intramolecular quadruplex conformation of human telomeric DNA assessed with 125I-radioprobing. 
\bibitem[8]{key8}Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter. 
\bibitem[9]{key9}A conformationally constrained nucleotide analogue controls the folding topology of a DNA g-quadruplex. 
\bibitem[10]{key10}Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex.
\bibitem[1]{key1}Thermodynamic, Anticoagulant, and Antiproliferative Properties of Thrombin Binding Aptamer Containing Novel UNA Derivative. 
\bibitem[2]{key2}Giardia telomeric sequence d(TAGGG)4 forms two intramolecular G-quadruplexes in K+ solution: effect of loop length and sequence on the folding topology. 
\bibitem[3]{key3}A novel chair-type G-quadruplex formed by a Bombyx mori telomeric sequence. 
\bibitem[4]{key4}Unfolding thermodynamics of intramolecular G-quadruplexes: base sequence contributions of the loops. 
\bibitem[5]{key5}Intramolecular quadruplex conformation of human telomeric DNA assessed with 125I-radioprobing. 
\bibitem[6]{key6}Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter. 
\bibitem[7]{key7}A conformationally constrained nucleotide analogue controls the folding topology of a DNA g-quadruplex.
\bibitem[1]{key1}Parallel folding topology-selective label-free detection and monitoring of conformational and topological changes of different G-quadruplex DNAs by emission spectral changes
\bibitem[2]{key2}Parallel G-Quadruplexes Formed by Guanine-Rich Microsatellite Repeats Inhibit Human Topoisomerase I. 
\bibitem[3]{key3}Loss of loop adenines alters human telomere d[AG3(TTAG3)3] quadruplex folding. 
\bibitem[4]{key4}Bulges in G-quadruplexes: broadening the definition of G-quadruplex-forming sequences. 
\bibitem[5]{key5}Solution-state structure of an intramolecular G-quadruplex with propeller, diagonal and edgewise loops. 
\bibitem[6]{key6}Structure of human telomeric DNA in crowded solution. 
\bibitem[7]{key7}Giardia telomeric sequence d(TAGGG)4 forms two intramolecular G-quadruplexes in K+ solution: effect of loop length and sequence on the folding topology. 
\bibitem[8]{key8}Duplex formation at the 5' end affects the quadruplex conformation of the human telomeric repeat overhang in sodium but not in potassium. \bibitem[9]{key9}Structure of the human telomere in K+ solution: a stable basket-type G-quadruplex with only two G-tetrad layers. 
\bibitem[10]{key10}Topology conservation and loop flexibility in quadruplex-drug recognition: crystal structures of inter- and intramolecular telomeric DNA quadruplex-drug complexes. 
\bibitem[11]{key11}The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex-interactive agents. 
\bibitem[12]{key12}Design and synthesis of an expanded porphyrin that has selectivity for the c-MYC G-quadruplex structure. 
\bibitem[13]{key13}Intramolecular quadruplex conformation of human telomeric DNA assessed with 125I-radioprobing. 
\bibitem[14]{key14}Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter. 
\bibitem[15]{key15}A conformationally constrained nucleotide analogue controls the folding topology of a DNA g-quadruplex. 
\bibitem[16]{key16}Crystal structure of parallel quadruplexes from human telomeric DNA.

\subsubsection{Heat Shock Proteins}

\bibitem[1]{key1}Inhibition of mouse RM-1 prostate cancer and B16F10 melanoma by the fusion protein of HSP65
\bibitem[1]{key1}Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents.
\bibitem[1]{key1}Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancer.
\bibitem[1]{key1}Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells.
\bibitem[1]{key1}Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells.
\bibitem[1]{key1}Proteomic characterization of early lung response to breast cancer metastasis in mice.
\bibitem[1]{key1}Verteporfin blocks Clusterin which is required for survival of gastric cancer stem cell by modulating HSP90 function.
\bibitem[1]{key1}Collateral sensitivity of natural products in drug-resistant cancer cells.
\bibitem[1]{key1}Muscadine grape skin extract inhibits prostate cancer cells by inducing cell-cycle arrest, and decreasing migration through heat shock protein 40.
\bibitem[1]{key1}C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.
\bibitem[1]{key1}Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer.
\bibitem[1]{key1}Profiling of apoptosis- and autophagy-associated molecules in human lung cancer A549 cells in response to cisplatin treatment using stable \bibitem[1]{key1}isotope labeling with amino acids in cell culture.
\bibitem[1]{key1}Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts.
\bibitem[1]{key1}Cabazitaxel inhibits prostate cancer cell growth by inhibition of androgen receptor and heat shock protein expression.
\bibitem[1]{key1}Hsp70 (HSP70A1A) downregulation enhances the metastatic ability of cancer cells.
\bibitem[1]{key1}ERp29 counteracts the suppression of malignancy mediated by endoplasmic reticulum stress and promotes the metastasis of colorectal cancer.
\bibitem[1]{key1}Heat shock proteins (HSPs): A novel target for cancer metastasis prevention.
\bibitem[1]{key1}Quantitative assessment of serum heat shock protein 27 for the diagnosis of epithelial ovarian cancer using targeted proteomics coupled with immunoaffinity enrichment.
\bibitem[1]{key1}TRPM7 overexpression enhances the cancer stem cell-like and metastatic phenotypes of lung cancer through modulation of the Hsp90a/uPA/MMP2 signaling pathway.
\bibitem[1]{key1}High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer.
\bibitem[1]{key1}Functional analysis of protein disulfide isomerase P5 in glioblastoma cells as a novel anticancer target.
\bibitem[1]{key1}Chaperome heterogeneity and its implications for cancer study and treatment.
\bibitem[1]{key1}A Novel Approach to Anticancer Therapy: Molecular Modules Based on the Barnase:Barstar Pair for Targeted Delivery of HSP70 to Tumor Cells.
Vorinostat enhances gefitinib-induced cell death through reactive oxygen species-dependent cleavage of HSP90 and its clients in non-small cell lung cancer with the EGFR mutation.
\bibitem[1]{key1}Genes involved in the regulation of different types of autophagy and their participation in cancer pathogenesis.
\bibitem[1]{key1}Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
\bibitem[1]{key1}Potential involvement of heat shock proteins in pancreatic-duodenal homeobox-1-mediated effects on the genesis of gastric cancer: A 2D gel-based proteomic study.

\subsection{Classroom Lecture 13-15 Topics: Machine Learning Models I, II and III}
\subsection{Classroom Lecture 16-18 Topics: Ribosome Model}
\subsection{Classroom Lecture 19-21 Topics: Chaperonin Model}

\bibitem[1]{key1}Pharmacological effectors of GRP78 chaperone in cancers.
\bibitem[1]{key1}Mass Spectrometric Quantification for the Binding Ratio of Metal-Based Anticancer Complexes with Protein Thiols.
\bibitem[1]{key1}Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells.
\bibitem[1]{key1}Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non-small-cell lung cancer cells.
\bibitem[1]{key1}Prostate-specific loss of UXT promotes cancer progression.
\bibitem[1]{key1}Expression of protein disulfide isomerase A3 and its clinicopathological association in gastric cancer.
\bibitem[1]{key1}Tumor cells induce LAMP2a expression in tumor-associated macrophage for cancer progression.
\bibitem[1]{key1}Combination therapies with HSP90 inhibitors against colorectal cancer.
\bibitem[1]{key1}MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions.
\bibitem[1]{key1}Spotlight on 17-AAG as an Hsp90 inhibitor for molecular targeted cancer treatment.
\bibitem[1]{key1}ASF1a inhibition induces p53-dependent growth arrest and senescence of cancer cells.
\bibitem[1]{key1}Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer.
\bibitem[1]{key1}Exosomes derived from HBV-associated liver cancer promote chemoresistance by upregulating chaperone-mediated autophagy.
\bibitem[1]{key1}Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation.
\bibitem[1]{key1}Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells.
\bibitem[1]{key1}ERp29 counteracts the suppression of malignancy mediated by endoplasmic reticulum stress and promotes the metastasis of colorectal cancer.
\bibitem[1]{key1}Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
\bibitem[1]{key1}The mitochondrial chaperone Prohibitin 1 negatively regulates interleukin-8 in human liver cancers.
\bibitem[1]{key1}Installation of a cancer promoting WNT/SIX1 signaling axis by the oncofusion protein MLL-AF9.
\bibitem[1]{key1}Heat shock proteins (HSPs): A novel target for cancer metastasis prevention.


\subsection{Classroom Lecture 22-24 Topics: Proteasome Model}
\subsection{Classroom Lecture 25-27 Topics: Network Models Molecular Machines I and II}

\bibitem[1]{key1}In silico perturbation of drug targets in pan-cancer analysis combining multiple networks and pathways. 
\bibitem[2]{key2}Integrated structural variation and point mutation signatures in cancer genomes using correlated topic models. 
\bibitem[3]{key3}Deep-Resp-Forest: A deep forest model to predict anti-cancer drug response. 
\bibitem[4]{key4}A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer. 
\bibitem[5]{key5}DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer. \bibitem[6]{key6}Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer. 
\bibitem[7]{key7}Identification of antiproliferative emodin analogues as inhibitors of epidermal growth factor receptor in cancer. \bibitem[8]{key8}Graph- and rule-based learning algorithms: a comprehensive review of their applications for cancer type classification and prognosis using genomic data. 
\bibitem[9]{key9}A novel gene selection algorithm for cancer classification using microarray datasets. 
\bibitem[10]{key10}Combining high wavenumber and fingerprint Raman spectroscopy for the detection of prostate cancer during radical prostatectomy. 
\bibitem[11]{key11}Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer. 
\bibitem[12]{key12}An isomiR expression panel based novel breast cancer classification approach using improved mutual information. \bibitem[13]{key13}The antinociceptive effect of resveratrol in bone cancer pain is inhibited by the Silent Information Regulator 1 inhibitor selisistat. 
\bibitem[14]{key14}Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time. 
\bibitem[15]{key15}CANDLE/Supervisor: a workflow framework for machine learning applied to cancer research. \bibitem[16]{key16}Synthetic lethal combinations of low-toxicity drugs for breast cancer identified <i>in silico 
\bibitem[17]{key17}Neuroevolution as a tool for microarray gene expression pattern identification in cancer research. 
\bibitem[18]{key18}The role of the molecular chaperone CCT in protein folding and mediation of cytoskeleton-associated processes: implications for cancer cell biology. 
\bibitem[19]{key19}[Precision screening and treatment of human papilloma virus related cervical cancer]. 
\bibitem[20]{key20}Computational analysis reveals histotype-dependent molecular profile and actionable mutation effects across cancers. \bibitem[21]{key21}Cross-cancer Prediction: A Novel Machine Learning Approach to Discover Molecular Targets for Development of Treatments for Multiple Cancers.

\subsection{Classroom Lecture 28-30 Topics: Application Study I, II and III}
\subsection{Topic A: Compound-Protein Interactions}

\bibitem[1]{key1}\href{https://www.ncbi.nlm.nih.gov//pubmed//30768156}{30768156}-DeepAffinity: Interpretable Deep Learning of Compound-Protein Affinity through Unified Recurrent and Convolutional Neural Networks. 
\bibitem[2]{key2}\href{https://www.ncbi.nlm.nih.gov//pubmed//30334207}{30334207}-Physicochemical Property Labels as Molecular Descriptors for Improved Analysis of Compound-Protein and Compound-Compound Networks. 
\bibitem[3]{key3}\href{https://www.ncbi.nlm.nih.gov//pubmed//30227391}{30227391}-Ecdysone Elicits Chronic Renal Impairment via Mineralocorticoid-Like Pathogenic Activities. 
\bibitem[4]{key4}\href{https://www.ncbi.nlm.nih.gov//pubmed//30111886}{30111886}-Activation of mineralocorticoid receptor by ecdysone, an adaptogenic and anabolic ecdysteroid, promotes glomerular injury and proteinuria involving overactive GSK3ß pathway signaling. 
\bibitem[5]{key5}\href{https://www.ncbi.nlm.nih.gov//pubmed//29997503}{29997503}-A Computational Systems Pharmacology Approach to Investigate Molecular Mechanisms of Herbal Formula Tian-Ma-Gou-Teng-Yin for Treatment of Alzheimer's Disease. 
\bibitem[6]{key6}\href{https://www.ncbi.nlm.nih.gov//pubmed//29982330}{29982330}-Compound-protein interaction prediction with end-to-end learning of neural networks for graphs and sequences. 
\bibitem[7]{key7}\href{https://www.ncbi.nlm.nih.gov//pubmed//29515774}{29515774}-Unbiased compound-protein interface mapping and prediction of chemoresistance loci through forward genetics in haploid stem cells. 
\bibitem[8]{key8}\href{https://www.ncbi.nlm.nih.gov//pubmed//28577120}{28577120}-Large-Scale Prediction of Drug-Target Interaction: a Data-Centric Review. 
\bibitem[9]{key9}\href{https://www.ncbi.nlm.nih.gov//pubmed//28456097}{28456097}-Structure-guided cancer blockade between bioactive bursehernin and proteins: Molecular docking and molecular dynamics study. 
\bibitem[10]{key10}\href{https://www.ncbi.nlm.nih.gov//pubmed//28263088}{28263088}-Active learning for computational chemogenomics. \
\bibitem[11]{key11}\href{https://www.ncbi.nlm.nih.gov//pubmed//28113437}{28113437}-Effectively Identifying Compound-Protein Interactions by Learning from Positive and Unlabeled Examples. 
\bibitem[12]{key12}\href{https://www.ncbi.nlm.nih.gov//pubmed//27530612}{27530612}-Identification of compound-protein interactions through the analysis of gene ontology, KEGG enrichment for proteins and molecular fragments of compounds. 
\bibitem[13]{key13}\href{https://www.ncbi.nlm.nih.gov//pubmed//27378654}{27378654}-Boosting compound-protein interaction prediction by deep learning. 
\bibitem[14]{key14}\href{https://www.ncbi.nlm.nih.gov//pubmed//27337171}{27337171}-TarNet: An Evidence-Based Database for Natural Medicine Research. 
\bibitem[15]{key15}\href{https://www.ncbi.nlm.nih.gov//pubmed//26888050}{26888050}-Pred-binding: large-scale protein-ligand binding affinity prediction. 


\subsection{Topic B:}
\subsection{Topic C:}
\subsection{Topic D:}
\subsection{Topic E:}




